May 5, 2025 8:30 AM EDT IR-MED Awarded $500,000 Grant from the Israel Innovation Authority to Advance AI-Powered DiaSafe(TM) Device for Diabetic Foot Ulcer Assessment
Mar 18, 2025 4:05 PM EDT IR-MED CEO Issues Letter to Shareholders: Expanding Our Platform and Presenting New Clinical Data from Israel and the U.S.
Mar 8, 2025 Visual and Near Infra-Red Spectroscopy Scanner for assessment of stage I pressure injury and deep tissue injury- final clinical study results